Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab. [electronic resource]
Producer: 20100330Description: 1001-4 p. digitalISSN:- 1432-0843
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived
- Antimetabolites, Antineoplastic -- adverse effects
- Blood Cell Count
- Blood Platelets -- metabolism
- Creatinine -- metabolism
- Deoxycytidine -- adverse effects
- Hemoglobins -- metabolism
- Hemolytic-Uremic Syndrome -- chemically induced
- Humans
- L-Lactate Dehydrogenase -- metabolism
- Male
- Middle Aged
- Purpura, Thrombotic Thrombocytopenic -- chemically induced
- Rituximab
- Gemcitabine
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.